Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2021-11-02 Board/Management Inform…
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Updates
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the re-appointment of the Managing Director and Joint Managing Director of the company. It references compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 and provides detailed profiles of the directors being re-appointed. There is no financial data, earnings information, or report content. The document is an announcement of changes in senior management positions, specifically the re-appointment of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a report publication notice but a formal management change disclosure.
2021-11-02 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges regarding a change in key managerial personnel, specifically the appointment of a new Chief Financial Officer (CFO). It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the appointment, including the date and profile of the new CFO. There is no financial data, report, or presentation included; rather, it is an official notification of a management change. This fits the category of Board/Management Information (MANG). The document length is 3433 characters, which is consistent with a typical management change announcement rather than a full report or detailed filing.
2021-11-02 English
Financial Result Updates
Interim / Quarterly Report Classification · 100% confidence The document is a submission to the National Stock Exchange of India and Bombay Stock Exchange of unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2021. It includes detailed financial statements such as income statement, statement of assets and liabilities, and cash flow statement. It also contains a Limited Review Report from the statutory auditors as per SEBI regulations. The presence of quarterly and half-year financial data, along with auditor review, indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, containing substantive financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2022
2021-11-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated October 22, 2021, addressed to stock exchanges regarding the schedule of a conference call meeting. It mentions the agenda as discussion on Q2FY22 results and future outlook. The document includes details for joining the call, such as dial-in numbers and contact information for RSVP. There are no financial statements, detailed analysis, or report content included. The document is an announcement of a conference call rather than the transcript or report itself. According to the classification rules, such a document is best classified as a Call Transcript (CT) if it contained the full transcript, but since this is only a schedule announcement, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the call schedule and does not contain the call transcript or financial data. The document length is short (2153 characters), supporting that it is an announcement rather than a full report or transcript.
2021-10-22 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (NSE and BSE) referencing Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It encloses a certificate from the Registrar and Share Transfer Agent for the quarter ended September 30, 2021. The document is short (1173 characters) and serves as a submission of a certificate rather than a full report or financial statement. It does not contain financial data or detailed report content but is a regulatory compliance submission. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2021-10-12 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (National Stock Exchange of India Limited and BSE Limited) regarding the publication of a Board Meeting Notice. It mentions that copies of the Notice of the Board Meeting were published in newspapers on October 12, 2021. The document is short (1057 characters) and serves as an announcement of the publication of a notice rather than the notice itself or any detailed report. There is no financial data, management discussion, or detailed report content. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about the publication of a notice.
2021-10-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.